Dr Gabriele Fontane > Oppenhoff > Frankfurt, Germany > Lawyer Profile
BOCKENHEIMER LANDSTRASSE 2-4
60306 FRANKFURT AM MAIN
- Go to...
Dr Gabriele Fontane
Corporate Law, Mergers and Acquisition, Private Equity
Gabriele Fontane joined Oppenhoff in 2018. Gabriele Fontane has been advising M&A and private equity transactions and on corporate law since the mid-1990ies, with a focus on MBO/LBO transactions. She is also specialized in acquisition finance and management participation programs. Among Gabriele Fontane’s clients are financial investors/private equity funds, corporates, MBO managers and entrepreneurs who consider selling their business.
Gabriele Fontane joined Oppenhoff in 2018. Before she was a founding partner of Otto Mittag Fontane, a law firm specialized in advising on M&A and private equity transactions, which was set up in 2009 in the course of a spin-off of Thümmel, Schütze & Partner’s Frankfurt office. Gabriele Fontane practiced at Thümmel, Schütze & Partner for 14 years, including 11 years as a partner of the firm. Since 2006 she is a lecturer on private equity at Frankfurt School of Finance & Management and recently became a member of its M&A board.
Since 2006 she is a lecturer on private equity at Frankfurt School of Finance & Management and recently became a member of its M&A board.
She studied law at Johann Wolfgang von Goethe University in Frankfurt am Main and started her career in 1993 as a foreign associate at Curtis, Mallet-Prevost, Colt & Mosle in New York.
Oppenhoff konnte 2020 die Themen medizinisches Cannabis und regulatorische Beratung zu Covid-19 erfolgreich besetzen, wobei schwerpunktmäßig zu Marktzugangs- und Erstattungsfragen beraten wurde. Im Pharmasektor prägten M&A-Transaktionen und streitige Verfahren das Mandatsaufkommen. Zunehmend ist die Kanzlei auch in der Venture Capital-Szene aktiv, beispielsweise für Healthcare-Start-ups. Das Thema Digitalisierung kann ebenfalls hausintern abgedeckt werden. Gabriele Fontane in Frankfurt leitet das Team.
In 2020, Oppenhoff advised on medical cannabis and regulatory matters in the context of Covid-19, market access and reimbursement issues were a particular focus. In the pharmaceutical space, the key areas are M&A transactions and litigation. The firm also increasingly handles venture capital mandates, for example for healthcare startups, and also covers digitisation matters. Gabriele Fontane in Frankfurt leads the team.
Top Tier Firm Rankings
- Trade and distribution > Foreign trade law
- Insurance > Advice to insurers
- Private clients and non-profits
- Industry focus > Healthcare and life sciences
- Information technology > Information technology and digitalisation
- Corporate and M&A > M&A: mid-sized deals (sub-€500m)
- Corporate and M&A > Corporate
- Information technology > Data protection
- Public sector > Planning and environment
- Public sector > Public procurement
- Trade and distribution > Trade, distribution and logistics